|
|
 |
|
Viewing report
|
|
|
|
Maximizing Prescribing Opportunities: Capitalizing on Primary and Secondary Care
Datamonitor, June 2004, Pages: 223
Introduction
Key findings indicate that pharmaceutical promotional campaigns have to be aligned with physicians’ exact information requirements if engagement and persuasion is to be increased. Consequently, the factors that feed into the decisions prescribers make when choosing one drug over another potential competitor have to be the core component of any targeting strategy
Scope
Identification of the major impacting factors on physician prescribing behavior, based on results from a survey of 85 doctors in the US, Europe, Japan
Assessment of physician perception of the effectiveness of components of the pharmaceutical promotional mix
Investigation of prescription behavior in the epilepsy, depression, dyslipidemia, gastrointestinal ulcers and asthma primary care in the US and Europe
Discussion of prescribing opportunities in secondary care, illustrated by reference to the arthritis and oncology sectors
Report Highlights
Detailing is proving to be the least effective component of a product’s promotional mix. Companies have to better address prescribers’ exact information requirements if buying is to be increased.
All physicians would normally prescribe the best-perceived treatment for an indication, despite its cost. For secondary care prescribers, however, the challenge is to justify the cost of an efficacious drug if payers disagree.
US-based physicians believe that the recent Medicare law changes will not enhance but only complicate current prescribing practice. Pharmaceutical marketers have to capitalize on any reimbursement opportunities that minimize prescribing indecision.
Reasons to Purchase
Understand why one drug is always prescribed over another, and how promotional activity can provide the ‘right’ information to the physician
Determine the effectiveness of detailing at influencing physicians’ prescribing behavior in both primary and secondary care markets
Identify high growth specialist disease markets that offer greater product margins for long-term portfolio growth
Customers who bought this item also bought
Maximizing Prescribing Opportunities: Capitalizing on Primary and Secondary Care
U.S. e-Prescribing Markets among Ambulatory Care Providers
Prescribing for Elderly Patients
Market Dynamics: Anti-dyslipidemics - Third Generation Statins Superfluous to Market Requirements?
Commercial Perspectives: Anti-dyslipidemics - A tale of two launches
Hypertension: Treatments and Prescribing Practices - A Global Survey
Anti-Aging Products - Global Strategic Business Report
Neuropathic Pain: Treatments and Prescribing Practices - A Global Survey 2009
China Anti-Diabetic Drug Market Report 2008
Stroke: Treatments and Prescribing Practices - A Global Survey 2009
Anti-aging Skincare in the United States
Anti-Aging & Beauty Attitudes And Behaviors
|
|
|
|
